Scienture Holdings, Inc. (NASDAQ: SCNX) Stock Competitors & Peer Comparison

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, RPRX has a market cap of 24.9B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while RPRX trades at $57.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas RPRX's P/E ratio is 10.71. In terms of profitability, SCNX's ROE is -0.54%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, SCNX is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check RPRX's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CORT has a market cap of 12.8B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CORT trades at $121.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CORT's P/E ratio is 338.69. In terms of profitability, SCNX's ROE is -0.54%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SCNX is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CORT's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas WBA's P/E ratio is -1.64. In terms of profitability, SCNX's ROE is -0.54%, compared to WBA's ROE of -0.57%. Regarding short-term risk, SCNX is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check WBA's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while KNSA trades at $80.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas KNSA's P/E ratio is 81.19. In terms of profitability, SCNX's ROE is -0.54%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SCNX is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check KNSA's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, LQDA has a market cap of 2.5B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while LQDA trades at $27.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas LQDA's P/E ratio is 20.45. In terms of profitability, SCNX's ROE is -0.54%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, SCNX is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check LQDA's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while PBH trades at $49.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas PBH's P/E ratio is 10.82. In terms of profitability, SCNX's ROE is -0.54%, compared to PBH's ROE of +0.09%. Regarding short-term risk, SCNX is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check PBH's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas HROWL's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, SCNX is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check HROWL's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas HROWM's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, SCNX is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check HROWM's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, LTGO has a market cap of 889.7M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while LTGO trades at $16.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas LTGO's P/E ratio is -5.87. In terms of profitability, SCNX's ROE is -0.54%, compared to LTGO's ROE of N/A. Regarding short-term risk, SCNX is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check LTGO's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, HELP has a market cap of 664.5M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while HELP trades at $11.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas HELP's P/E ratio is -2.57. In terms of profitability, SCNX's ROE is -0.54%, compared to HELP's ROE of -0.71%. Regarding short-term risk, SCNX is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check HELP's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while SVA trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas SVA's P/E ratio is -5.68. In terms of profitability, SCNX's ROE is -0.54%, compared to SVA's ROE of -0.01%. Regarding short-term risk, SCNX is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check SVA's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CUVL has a market cap of 281.4M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CUVL trades at $5.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CUVL's P/E ratio is 12.04. In terms of profitability, SCNX's ROE is -0.54%, compared to CUVL's ROE of N/A. Regarding short-term risk, SCNX is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CUVL's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CELG-RI has a market cap of 233.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CELG-RI trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, SCNX is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check CELG-RI's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while HITI trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas HITI's P/E ratio is -9.53. In terms of profitability, SCNX's ROE is -0.54%, compared to HITI's ROE of -0.36%. Regarding short-term risk, SCNX is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check HITI's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, ETRA has a market cap of 193.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while ETRA trades at $9.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas ETRA's P/E ratio is -3.45. In terms of profitability, SCNX's ROE is -0.54%, compared to ETRA's ROE of N/A. Regarding short-term risk, SCNX is more volatile compared to ETRA. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check ETRA's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CTOR has a market cap of 78.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CTOR trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CTOR's P/E ratio is -1.81. In terms of profitability, SCNX's ROE is -0.54%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, SCNX is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CTOR's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while ATLN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas ATLN's P/E ratio is -0.68. In terms of profitability, SCNX's ROE is -0.54%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, SCNX is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check ATLN's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas RAD's P/E ratio is -0.05. In terms of profitability, SCNX's ROE is -0.54%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SCNX is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check RAD's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SCNX's ROE is -0.54%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, SCNX is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check GLTO's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, NSRX has a market cap of 30.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while NSRX trades at $3.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas NSRX's P/E ratio is -4.99. In terms of profitability, SCNX's ROE is -0.54%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, SCNX is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check NSRX's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, SCYX has a market cap of 26.5M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while SCYX trades at $4.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas SCYX's P/E ratio is -1.23. In terms of profitability, SCNX's ROE is -0.54%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, SCNX is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check SCYX's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, COSM has a market cap of 17.1M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while COSM trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas COSM's P/E ratio is -0.43. In terms of profitability, SCNX's ROE is -0.54%, compared to COSM's ROE of -1.19%. Regarding short-term risk, SCNX is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check COSM's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CNSY has a market cap of 12.3M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CNSY trades at $1.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CNSY's P/E ratio is -0.43. In terms of profitability, SCNX's ROE is -0.54%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, SCNX is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CNSY's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, BFRI has a market cap of 11.8M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while BFRI trades at $0.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas BFRI's P/E ratio is -1.67. In terms of profitability, SCNX's ROE is -0.54%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, SCNX is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check BFRI's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SCNX's ROE is -0.54%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SCNX is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CJJD's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas SSY's P/E ratio is -2.86. In terms of profitability, SCNX's ROE is -0.54%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SCNX is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check SSY's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, POM has a market cap of 5.4M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while POM trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas POM's P/E ratio is -0.11. In terms of profitability, SCNX's ROE is -0.54%, compared to POM's ROE of +0.16%. Regarding short-term risk, SCNX is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check POM's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, BGMS has a market cap of 4.5M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while BGMS trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas BGMS's P/E ratio is -0.23. In terms of profitability, SCNX's ROE is -0.54%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, SCNX is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check BGMS's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, BFRIW has a market cap of 4.3M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while BFRIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, SCNX's ROE is -0.54%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, SCNX is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check BFRIW's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, EOCN has a market cap of 3.8M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while EOCN trades at $3.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas EOCN's P/E ratio is -0.26. In terms of profitability, SCNX's ROE is -0.54%, compared to EOCN's ROE of N/A. Regarding short-term risk, SCNX is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check EOCN's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, PAVS has a market cap of 3.1M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while PAVS trades at $3.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas PAVS's P/E ratio is -0.04. In terms of profitability, SCNX's ROE is -0.54%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, SCNX is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check PAVS's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SCNX's ROE is -0.54%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SCNX is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check MDVL's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, SCNX is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check ATNFW's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SCNX's ROE is -0.54%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, SCNX is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check BGMSP's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while AZNH trades at $53.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SCNX's ROE is -0.54%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SCNX is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check AZNH's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SCNX's ROE is -0.54%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SCNX is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check LFLYW's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, PRPH has a market cap of 140.2K. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while PRPH trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas PRPH's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, SCNX is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check PRPH's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, OREX has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas OREX's P/E ratio is -0.14. In terms of profitability, SCNX's ROE is -0.54%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SCNX is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check OREX's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas SHPG's P/E ratio is 11.35. In terms of profitability, SCNX's ROE is -0.54%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, SCNX is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check SHPG's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SCNX's ROE is -0.54%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SCNX is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check IPXL's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, CPD has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas CPD's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to CPD's ROE of N/A. Regarding short-term risk, SCNX is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check CPD's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, POZN has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas POZN's P/E ratio is N/A. In terms of profitability, SCNX's ROE is -0.54%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SCNX is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for SCNX.Check POZN's competition here

Scienture Holdings, Inc. (NASDAQ: SCNX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCNX stands at 6.3M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SCNX is priced at $3.68 on the NASDAQ, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCNX currently has a P/E ratio of -1.84, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SCNX's ROE is -0.54%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SCNX is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for SCNX.Check ESRX's competition here